These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 15842987)
21. Arg389Gly-beta1-adrenergic receptors determine improvement in left ventricular systolic function in nonischemic cardiomyopathy patients with heart failure after chronic treatment with carvedilol. Chen L; Meyers D; Javorsky G; Burstow D; Lolekha P; Lucas M; Semmler AB; Savarimuthu SM; Fong KM; Yang IA; Atherton J; Galbraith AJ; Parsonage WA; Molenaar P Pharmacogenet Genomics; 2007 Nov; 17(11):941-9. PubMed ID: 18075464 [TBL] [Abstract][Full Text] [Related]
22. Role of beta-adrenergic receptor gene polymorphisms in the long-term effects of beta-blockade with carvedilol in patients with chronic heart failure. Metra M; Covolo L; Pezzali N; Zacà V; Bugatti S; Lombardi C; Bettari L; Romeo A; Gelatti U; Giubbini R; Donato F; Dei Cas L Cardiovasc Drugs Ther; 2010 Feb; 24(1):49-60. PubMed ID: 20352314 [TBL] [Abstract][Full Text] [Related]
23. The effects of combined versus selective adrenergic blockade on left ventricular and systemic hemodynamics, myocardial substrate preference, and regional perfusion in conscious dogs with dilated cardiomyopathy. Nikolaidis LA; Poornima I; Parikh P; Magovern M; Shen YT; Shannon RP J Am Coll Cardiol; 2006 May; 47(9):1871-81. PubMed ID: 16682315 [TBL] [Abstract][Full Text] [Related]
24. Usefulness of carvedilol to abolish myocardial postsystolic shortening in patients with idiopathic dilated cardiomyopathy. Ito T; Kawanishi Y; Futai R; Terasaki F; Kitaura Y Am J Cardiol; 2009 Dec; 104(11):1568-73. PubMed ID: 19932794 [TBL] [Abstract][Full Text] [Related]
25. Plasma brain natriuretic peptide as a novel therapeutic indicator in idiopathic dilated cardiomyopathy during beta-blocker therapy: a potential of hormone-guided treatment. Kawai K; Hata K; Takaoka H; Kawai H; Yokoyama M Am Heart J; 2001 Jun; 141(6):925-32. PubMed ID: 11376305 [TBL] [Abstract][Full Text] [Related]
26. Comparative hemodynamic, left ventricular functional, and antiadrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart. Gilbert EM; Abraham WT; Olsen S; Hattler B; White M; Mealy P; Larrabee P; Bristow MR Circulation; 1996 Dec; 94(11):2817-25. PubMed ID: 8941107 [TBL] [Abstract][Full Text] [Related]
27. Comparative efficacy of nebivolol versus carvedilol on left ventricular function and exercise capacity in patients with nonischemic dilated cardiomyopathy. A 12-month study. Patrianakos AP; Parthenakis FI; Mavrakis HE; Diakakis GF; Chlouverakis GI; Vardas PE Am Heart J; 2005 Nov; 150(5):985. PubMed ID: 16290981 [TBL] [Abstract][Full Text] [Related]
28. Effect of left ventricular reverse remodeling on long-term prognosis after therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and β blockers in patients with idiopathic dilated cardiomyopathy. Hoshikawa E; Matsumura Y; Kubo T; Okawa M; Yamasaki N; Kitaoka H; Furuno T; Takata J; Doi YL Am J Cardiol; 2011 Apr; 107(7):1065-70. PubMed ID: 21296328 [TBL] [Abstract][Full Text] [Related]
29. Carvedilol or sustained-release metoprolol for congestive heart failure: a comparative effectiveness analysis. Shore S; Aggarwal V; Zolty R J Card Fail; 2012 Dec; 18(12):919-24. PubMed ID: 23207080 [TBL] [Abstract][Full Text] [Related]
30. Different effects of carvedilol, metoprolol, and propranolol on left ventricular remodeling after coronary stenosis or after permanent coronary occlusion in rats. Yaoita H; Sakabe A; Maehara K; Maruyama Y Circulation; 2002 Feb; 105(8):975-80. PubMed ID: 11864928 [TBL] [Abstract][Full Text] [Related]
32. [A failed improvement in pulmonary function and exercise capacity with carvedilol in congestive heart failure despite an excellent effect on left ventricular function]. Guazzi M; Pontone G; Trevisi N; Lomanto M; Matturri M; Agostoni P Cardiologia; 1998 Feb; 43(2):181-7. PubMed ID: 9557374 [TBL] [Abstract][Full Text] [Related]
33. Carvedilol versus metoprolol in the acute phase of myocardial infarction: Bonnemeier H; Ortak J; Tölg R; Witt M; Schmidt J; Wiegand UK; Bode F; Schunkert H; Richardt G Pacing Clin Electrophysiol; 2005 Jan; 28 Suppl 1():S222-6. PubMed ID: 15683501 [TBL] [Abstract][Full Text] [Related]
34. Effects of carvedilol on left ventricular diastolic function and chamber volumes in advanced heart failure. Palazzuoli A; Quatrini I; Vecchiato L; Scali C; De Paola V; Iovine F; Martini G; Nuti R Minerva Cardioangiol; 2005 Aug; 53(4):321-8. PubMed ID: 16177676 [TBL] [Abstract][Full Text] [Related]
35. Comparative left ventricular functional and neurohumoral effects of chronic treatment with carvedilol versus metoprolol in patients with dilated cardiomyopathy. Hirooka K; Yasumura Y; Ishida Y; Hanatani A; Nakatani S; Komamura K; Hori M; Yamagishi M; Miyatake K Jpn Circ J; 2001 Nov; 65(11):931-6. PubMed ID: 11716241 [TBL] [Abstract][Full Text] [Related]
36. Exchange of beta-blockers in heart failure patients. Experiences from the poststudy phase of COMET (the Carvedilol or Metoprolol European Trial). Di Lenarda A; Remme WJ; Charlesworth A; Cleland JG; Lutiger B; Metra M; Komajda M; Torp-Pedersen C; Scherhag A; Swedberg K; Poole-Wilson PA; Eur J Heart Fail; 2005 Jun; 7(4):640-9. PubMed ID: 15921806 [TBL] [Abstract][Full Text] [Related]
37. Does beta-blocker treatment influence central sleep apnoea? Köhnlein T; Welte T Respir Med; 2007 Apr; 101(4):850-3. PubMed ID: 17223328 [TBL] [Abstract][Full Text] [Related]
38. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial. Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026 [TBL] [Abstract][Full Text] [Related]